Evvy, a New York, NY-based female-founded startup that aims to build a new understanding of the female body, launched with $5m in seed funding.
Backers included General Catalyst, Box Group, Virtue, Human Ventures, G9 Ventures, BBG Ventures, and others. Margo Georgiadis, Executive-in-Residence at General Catalyst and former CEO of one of the world’s largest at-home testing companies, Ancestry, has joined Evvy’s board.
The company plans to use the funds to continue to expand operations, its development efforts and business reach.
Co-founded by Stanford alumni CEO Priyanka Jain and CMO Laine Bruzek, Evvy is introducing an at-home vaginal microbiome test leveraging metagenomic sequencing to demystify Yeast Infections, BV, Chronic UTIs, and the vaginal microbiome’s newly discovered role in fertility and overall female health.
The Evvy Vaginal Health Test is available in all 50 states and performed as a simple, at-home swab. Test results are delivered back after 2 weeks in a personal, private online dashboard with actionable results, curated insights on how vaginal microbiome is related to holistic health & recommendations based on a unique health context.
As of July 14th, Evvy’s test will be available in all 50 states at evvy.com for $129.
The company is already planning to expand into new biomarkers and datasets.